Organogenesis Holdings Inc.·4

Feb 20, 5:26 PM ET

Duraibabu Prathyusha 4

Research Summary

AI-generated summary

Updated

Organogenesis (ORGO) Director Prathyusha Receives RSU Award

What Happened

  • Director Duraibabu Prathyusha received a grant of 48,828 restricted stock units (RSUs) on Feb 18, 2026. The Form 4 lists the acquisition price as $0.00, reflecting an equity award rather than a market purchase or sale.

Key Details

  • Transaction date: February 18, 2026; Form 4 filed February 20, 2026 (within the typical 2-business-day reporting window).
  • Grant: 48,828 RSUs; price reported: $0.00; reported dollar value for the transaction: $0.
  • Vesting: The RSUs vest in full on February 15, 2027 (per filing footnote).
  • Shares owned after the transaction: not specified in the provided filing details.
  • Filing type: Award/Grant (code A). No 10b5-1 plan, tax-withholding sale, or late-filing indication noted in the filing.

Context

  • RSUs are a form of compensation that convert to shares upon vesting; this award gives Prathyusha the contingent right to receive one Class A share per RSU on vesting (Feb 15, 2027). Such grants are routine compensation for executives or directors and do not directly signal open-market buying or selling by the insider.